KPC Pharmaceuticals Inc
SSE:600422

Watchlist Manager
KPC Pharmaceuticals Inc Logo
KPC Pharmaceuticals Inc
SSE:600422
Watchlist
Price: 15.25 CNY -2.49% Market Closed
Market Cap: 11.5B CNY
Have any thoughts about
KPC Pharmaceuticals Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

19.1
Current
21.1
Median
13.7
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
19.1
=
Enterprise Value
10.8B CNY
/
EBITDA
565.8m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
12.7
2-Years Forward
EV/EBITDA
10.4
3-Years Forward
EV/EBITDA
8.7

See Also

Discover More